February 2, 2022

Press Release

Syz Capital partner with Saturnus Capital to take controlling stake in leading German Pharmaceutical Logistics firm, SK Pharma

SK Pharma is one of Germany’s leading pharmaceutical pre-wholesalers. Syz Capital is a boutique private markets investor providing exclusive access to niche investments in private equity and alternative investments. Saturnus Capital is a private equity firm focused on mid-market transactions in the DACH region.

Syz Capital, the boutique private markets investment specialist, announced today that it has taken a controlling stake in SK Pharma Logistics, specialized in storing, handling, repackaging and distributing pharmaceutical products. Backed by the Syz Family and in close partnership with Saturnus Capital, Syz Capital is looking to grow and accelerate the expansion of this strong market leader, bringing it to new heights. Based in Bielefeld, Germany, SK Pharma is a family-owned business servicing both European and Global pharmaceutical companies. A leader in the space, the company specializes in pharmaceutical and medical grade products, as well as cosmetics and dietary products. The company offers the entire value chain of logistics, offering its customer turnkey solutions. The company has been growing impressively, averaging a CAGR of 28% in the last 3 years, 7x faster than the healthcare industry in Germany over the last 10 years. The firm expects further growth as the regulatory environment is becoming stricter and the underlying industry is forecasted to grow consistently over the next few years. Marc Syz, Managing Partner of Syz Capital, says: “We believe there is a unique opportunity to help this entrepreneurial family business expand its business and footprint organically and by acquisition, consolidating the relatively fragmented sector serving global customers. With SK Pharma, we truly have found another hidden champion which offers a strong platform to drive future value creation.” “The deal also demonstrates the potential value creation we can add to our clients’ portfolios and underlines how Syz Capital is unlocking unique synergistic opportunities in the private equity and alternatives space.” Joscha Boehm, Managing Partner of Saturnus Capital, and Philipp Schweizer, Partner of Saturnus Capital, who teamed up with Syz Capital for this transaction commented: “We are excited to be closely working with the founders and the management team to further develop SK Pharma in the coming years. We consider SK Pharma to be a well-run business that is uniquely positioned to continue to grow and gain market share.” This acquisition marks another important milestone for Syz Capital in the family businesses landscape. Both Saturnus and Marc Syz will join the SK Pharma Board of Directors along the Krone family and Philippe Milliet, a former Galenica executive and industry veteran. Stephan Krone, CEO of SK Pharma Logistics GmbH, added: “We believe Syz Capital and Saturnus Capital are ideal partners with significant experience investing in family-owned businesses to drive SK Pharma through its next growth phase and beyond, to create value for our customers and partners. They have a clear growth strategy for the future, the management team and myself are excited to partner with them and, together, build SK Pharma into a leading European player in the Pharma Logistics Industry.”
All Alternative Investment Insights Asset Allocation Insights Corporate News Press Release Educational Videos
January 29, 2026

Best Year in Over a Decade

Global financial markets posted positive but uneven performance in the second half of 2025. Equities were supported by resilient earnings, easing inflation, and expectations of policy easing, though volatility emerged around AI valuations, shifting Fed rate expectations, and geopolitical and trade risks. U.S. equities outperformed, driven by technology and AI themes, while Europe and Asia were more mixed. Bond markets reflected a move toward easing policy, with yields declining later in the period, and the U.S. dollar weakening despite volatility. Commodities were mixed, with strength in precious metals and select energy offset by weakness in oil and agriculture. Credit markets benefited from improved risk appetite, with emerging market local currency debt among the stronger performers late in the year.
January 12, 2026

Final Closing of Themis II

We are pleased to announce the final closing of Themis II, the second vintage of our Litigation Finance strategy, which closed on 31 December 2025 with over USD 105 million in commitments.
December 18, 2025

Syz Capital Hosts Legal Assets Webinar in Partnership with CAIA Association

Syz Capital was pleased to host a dedicated webinar on Legal Assets on Thursday, November 2025, in partnership with CAIA Association, bringing together investment professionals to discuss an increasingly relevant segment of alternative investments.
July 11, 2025

Riding the waves of dispersion

Global markets saw mixed but ultimately positive performance in H1. January opened strong, driven by policy shifts and gains in energy, healthcare, and European equities. February and March were volatile as trade tariff concerns weighed on sentiment, with US tech leading losses and growth stocks sharply underperforming value. Interest rates fell globally early in the period, except for the US where the Dollar fluctuated, and commodities were mixed. April brought heightened volatility but improved sentiment by month-end, with renewed optimism around trade negotiations and potential rate cuts. May saw a strong rebound, led by technology and improving global growth prospects, with Germany and Japan topping regional equity gains. Overall, risk appetite recovered heading into summer.
May 27, 2025

Syz Capital Alternative Summit 2025

Syz Capital, the $2 billion alternatives investment arm of the family-owned Syz Group, proudly presents the Syz Alternative Summit Summary. This event brought together industry leaders, investors, and innovators to explore the future of alternative investments and digital assets.
March 10, 2025

Syz Capital selects Coinbase to launch innovative BTC Alpha Fund

Syz Capital, the $2 billion alternatives investment arm of the family-owned Syz Group, has launched the Syz Capital BTC Alpha Fund, with Coinbase as Prime Broker and Custodian. This pioneering fund of crypto hedge funds taps into volatility, market inefficiencies, and fragmented liquidity to deliver low volatility uncorrelated returns, denominated in bitcoin – a first for any financial institution globally. Building on the 2023 launch of SyzCrest—now a global leader in crypto hedge fund allocation—the new bitcoin-denominated, market-neutral fund underscores Syz Group’s mission to be a leader in new innovations in the digital asset space.
February 28, 2025

Dynamics of the liquidity slowdown in Private Equity

Exploring the key drivers behind the recent decline in PE exit activity
February 1, 2025

Hedge Funds on a Winning Streak, What’s Next for 2025?

The second half of 2024 saw a number of big events and significant market moves. In August, Japan’s Nikkei plunged over 12%, triggering global market volatility as traders unwound FX carry trades. The S&P 500 dropped and VIX spiked to 65. In response, the Fed cut rates by 50bp in September and a further 25bp in November and December. Trump’s election win and a Republican sweep led to market optimism, pushing the S&P 500 past 6,000 amid expectations of tax cuts and deregulation. Concerns persist over China’s weak growth and potential Taiwan tensions. In the US, despite valuation worries, strong economic growth and pro-business policies suggest a favorable market setup heading into 2025.
December 23, 2024

David vs. Goliath in Private Equity

The battle for returns: Lower Mid-Market vs. large-cap
November 14, 2024

Syz Capital backs Riverdam in the creation of a leading MSP platform

Syz Capital is delighted to announce its co-investment in the Managed IT Service Providers Platform of the investment company Riverdam. This deal marks the fifth investment for our multi-strategy Private Equity fund, now showing a strong and well-seeded portfolio. This investment continues to demonstrate Syz Capital’s capability of leveraging longstanding relationships in the Private Equity market to co-invest alongside leading sponsors and management teams in high-potential Lower Mid-Market companies.
November 13, 2024

Ursula Nitschke joins Syz Capital as Head of Business Development & IR

Ursula Nitschke has been appointed to the role of Head of Business Development and Investor Relations at Syz Capital, the $1.8bln alternatives investment arm of the family owned Syz Group.
November 2, 2024

Syz Capital with operating partners Saturnus Capital take majority stake in digital marketing pioneer Capture Media

Capture Media is the fastest-growing Engagement Advertising Provider in Switzerland. The strategy will focus to further accelerate product innovation, expand geographic reach and develop M&A opportunities. SYZ Capital is a boutique private markets investor providing exclusive access to niche investments in private equity and alternative investments. Saturnus Capital is a private equity specialist focused on mid-market transactions in the DACH region.
May 15, 2023

Syz partners with Willy Woo and CMCC to launch first bank-backed crypto hedge fund

Syz Group has partnered with CMCC Global to launch SyzCrest Digital Uncorrelated – a fund of crypto hedge funds. SyzCrest brings together some of the most renowned experts in the traditional hedge fund world and the crypto and digital asset ecosystem. The strategy will be available to investors from July 1st.
February 9, 2022

The calm after the storm?

It has been a rough start to 2022 for risk assets as expectations of more rapid monetary policy tightening and inflation concerns pushed equities and bonds to sell-off simultaneously. The biggest macroeconomic development so far in 2022 is undoubtedly the hawkish pivot by both the US Federal Reserve and the European Central Bank in response to persistent inflation. But after a hectic January, and despite widening credit and European periphery spreads, global stocks saw some sense of calm return last week with narrowed down intraday swings.
February 2, 2022

Syz Capital partner with Saturnus Capital to take controlling stake in leading German Pharmaceutical Logistics firm, SK Pharma

SK Pharma is one of Germany’s leading pharmaceutical pre-wholesalers. Syz Capital is a boutique private markets investor providing exclusive access to niche investments in private equity and alternative investments. Saturnus Capital is a private equity firm focused on mid-market transactions in the DACH region.

Disclaimer

This marketing document has been issued by Syz Capital AG. It is not intended for distribution to, publication, provision or use by individuals or legal entities that are citizens of or reside in a state, country or jurisdiction in which applicable laws and regulations prohibit its distribution, publication, provision or use. It is not directed to any person or entity to whom it would be illegal to send such marketing material. This document is intended for informational purposes only and should not be construed as an offer, solicitation or recommendation for the subscription, purchase, sale or safekeeping of any security or financial instrument or for the engagement in any other transaction, as the provision of any investment advice or service, or as a contractual document. Nothing in this document constitutes an investment, legal, tax or accounting advice or a representation that any investment or strategy is suitable or appropriate for an investor’s particular and individual circumstances, nor does it constitute a personalized investment advice for any investor. This document reflects the information, opinions and comments of Syz Capital AG as of the date of its publication, which are subject to change without notice. The opinions and comments of the authors in this document reflect their current views and may not coincide with those of other Syz Group entities or third parties, which may have reached different conclusions. The market valuations, terms and calculations contained herein are estimates only. The information provided comes from sources deemed reliable, but Syz Capital AG does not guarantee its completeness, accuracy, reliability and actuality. Past performance gives no indication of nor guarantees current or future results. Syz Capital AG accepts no liability for any loss arising from the use of this document.

gymclothesshop.com

To behold a finely finished movement through a sapphire crystal case back is to witness a world of sublime artistry. Bridges and plates are adorned with Côtes de Genève, stripes that mimic the gentle waves of Lake Geneva, not merely for beauty but to trap dust.

Edges are bevelled and polished to a razor-sharp gleam, a testament to hours of patient work by a craftsman’s hand. Screw heads are polished and their slots perfectly aligned. Tiny jewels, synthetic rubies, are set into the movement to act as near-frictionless bearings for the pivots.